Clinical Trial

Growth Hormone Resistance of Beta-cells

Study acronym: GHRB-C
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with impaired fasting glucose or impaired glucose tolerance at the University of Missouri. The aim of the study is to advance understanding of how growth hormone affects beta-cells and risk factors for developing type 2 diabetes.
Trial Details
NCT Number NCT07581860
Lead Sponsor University of Missouri-Columbia
Conditions Healthy, Obesity & Overweight, Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (Prediabetes)
Enrollment 10 participants
Start Date 2026-08-01
Primary Completion 2028-09-01 (estimated)
Study Completion 2030-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-06